Abstract: Furthermore,
NSP12 323L variant, encoded by the SARS-CoV-2
C14408T variant first detected in Lombardy, Italy, that carries a
Pro323Leu amino acid substitution in
NSP12, showed increased ability to activate
Discussion: Furthermore, the increased ability of SARS-CoV-2 323L variant to stimulate RIPK1 activation and replicate in the lung organoids also suggests that the
NSP12 P323L mutation may contribute to the spread of this SARS-CoV-2 variant around the world.
Discussion: In addition, since the structural changes in
NSP12 introduced by
P323L mutation may contribute to the resistance to remesdesivir, RIPK1 inhibition may offer a therapeutic strategy to reduce viral propagation.